Search

everythinglearnresearchcommunity

for

Search:↓

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Most people in South India lack knowledge about managing COVID-19 at home.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

The pandemic worsened physical and mental challenges for women with PCOS.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

Certain alkaloids could help create new coronavirus drugs.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

COVID-19 may cause hair loss by affecting hair follicles.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

Stress and COVID-19 can worsen hair loss conditions like alopecia areata.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss has many causes and treatments, but future research aims for better solutions.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

A woman's hair loss improved with treatment after a COVID-19 infection.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

An 11-year-old girl's hair loss was caused by a Cladosporium fungal infection, which was cured with itraconazole treatment.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.